Kenworthy Capital Shows Early Returns and Continues to Grow With a Focus on Giving Back

Thursday, August 1, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

"Kenworthy Capital shows over 60% gains to instill greater confidence in investors looking to maintain their financial status and wishing to be a part of a movement to drive social change."

BOSTON, Aug. 1, 2019 /PRNewswire-PRWeb/ -- Impact investment funds are a unique form of financial investments that have

been designed to balance out corporate social responsibility with financial gain for the investor. In light of the funding deficit in autoimmune disease research and the immediate attention required to reverse the effects of climate change, Kenworthy Capital has recently been launched to raise funds for the two movements.

Although still in its nascent stages, Kenworthy Capital has outperformed market indexes by offering returns as high as 60% this early in its lifetime. As a testament to their commitment the company is currently donating a percentage of the income to celiac disease research. Many agree with the goals of the investment fund, grateful to have the opportunity to become part of two of the biggest challenges faced by modern society.

When asked for a comment, Randal Kenworthy had this to offer:

"When the decision to form Kenworthy Capital was finalized, we weren't sure how many people would get behind the values we represented. Auto-immune disease research is under-funded at the moment and climate change reversal is a long-term effort. But much to our surprise and gratitude, we've had a lot of interest in Kenworthy Capital and we're glad to be delivering back to them while at the same time offering them the opportunity to become part of something greater."

In a time when many were wondering if it was possible for private investors to provide active support to humanitarian goals, Kenworthy Capital is testament to the willingness to work towards social benefit. With the efforts on part of the team at Kenworthy Capital, it seems clear that impact-investment has the potential to turn the tide against the advance of auto-immune diseases and the climate crisis.

It's projects like Kenworthy Capital, that combine financial innovation and embody the values of common good that are needed to help overcome the challenges that humanity faces. Facing these challenges will require large-scale research mobilization that Kenworthy Capital is trying to amass.

About Kenworthy Capital Kenworthy Capital is an early stage impact investment fund that caters to climate change and auto-immune disease research. Contributing a part of incomes to either of these movements, Kenworthy Capital balances out financial returns with awareness efforts for the environment and public health.

Contact Information: Website: https://www.randalkenworthy.com/ Email: kenworthycapital(at)gmail.com

 

SOURCE Kenworthy Capital



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store